Results 141 to 150 of about 16,226 (208)

Resistome of Staphylococcus aureus in Response to Human Cathelicidin LL-37 and Its Engineered Antimicrobial Peptides. [PDF]

open access: yesACS Infect Dis, 2020
Golla RM   +6 more
europepmc   +1 more source

The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics. [PDF]

open access: yesSci Rep, 2020
Sancho-Vaello E   +7 more
europepmc   +1 more source

Brief Report: Increased Cotinine Concentrations are Associated With Reduced Expression of Cathelicidin (LL-37) and NOD-2 in Alveolar Macrophages of PLWH Who Smoke. [PDF]

open access: yesJ Acquir Immune Defic Syndr, 2020
Diaz PT   +8 more
europepmc   +1 more source

Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37. [PDF]

open access: yesACS Infect Dis, 2021
Lakshmaiah Narayana J   +9 more
europepmc   +1 more source

Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice. [PDF]

open access: yesAntibiotics (Basel)
Gasanov VAO   +8 more
europepmc   +1 more source

Synthetic cathelicidin LL-37 reduces Mycobacterium avium subsp. paratuberculosis internalization and pro-inflammatory cytokines in macrophages. [PDF]

open access: yesCell Tissue Res, 2020
Cirone KM   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy